Get the latest Science News and Discoveries

Breaking Free From Meth: UCLA’s Dual Drug Therapy Proves Effective in Clinical Trials


Research from UCLA demonstrated that a combination therapy of naltrexone and bupropion effectively reduced methamphetamine use in trial participants over 12 weeks, suggesting the potential of pharmacological interventions in addressing rising overdose rates. A clinical trial on a two-drug therapy

None

Get the Android app

Or read this on SciTech Daily

Read more on:

Photo of clinical trials

clinical trials

Photo of dual drug therapy

dual drug therapy

Photo of UCLA

UCLA

Related news:

News photo

U.S. clinical trials begin for twice-yearly HIV prevention injection - EurekAlert

News photo

Clinical trials show promise in treating central nervous system lymphoma, breast cancer, and glioblastoma - EurekAlert

News photo

It Is Too Soon for Clinical Trials on Artificial Wombs